Envista (NVST) Scheduled to Post Earnings on Wednesday

Envista (NYSE:NVSTGet Free Report) will issue its quarterly earnings data after the market closes on Wednesday, May 1st. Analysts expect the company to announce earnings of $0.31 per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.

Envista (NYSE:NVSTGet Free Report) last posted its quarterly earnings data on Wednesday, February 7th. The company reported $0.29 earnings per share for the quarter, missing the consensus estimate of $0.33 by ($0.04). Envista had a positive return on equity of 6.31% and a negative net margin of 3.90%. The business had revenue of $645.60 million during the quarter, compared to the consensus estimate of $638.37 million. During the same period last year, the business posted $0.52 earnings per share. The business’s revenue was down 2.3% on a year-over-year basis. On average, analysts expect Envista to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Envista Stock Performance

NVST stock opened at $20.39 on Monday. The stock has a 50-day moving average price of $20.95 and a 200-day moving average price of $22.67. Envista has a 1-year low of $18.95 and a 1-year high of $38.68. The company has a current ratio of 2.23, a quick ratio of 1.90 and a debt-to-equity ratio of 0.33. The firm has a market cap of $3.50 billion, a PE ratio of -33.43, a price-to-earnings-growth ratio of 3.81 and a beta of 1.35.

Analyst Ratings Changes

Several brokerages have recently commented on NVST. William Blair downgraded Envista from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 8th. Morgan Stanley downgraded Envista from an “overweight” rating to an “equal weight” rating and reduced their target price for the company from $33.00 to $21.00 in a research note on Friday. UBS Group began coverage on Envista in a research note on Friday, January 5th. They issued a “neutral” rating and a $26.00 target price for the company. TheStreet downgraded Envista from a “c” rating to a “d+” rating in a research note on Wednesday, February 7th. Finally, Leerink Partnrs restated an “underperform” rating on shares of Envista in a research note on Monday, February 26th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat, Envista presently has an average rating of “Hold” and a consensus target price of $27.90.

Check Out Our Latest Stock Analysis on Envista

About Envista

(Get Free Report)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

Featured Articles

Earnings History for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.